CUPERTINO, Calif., Sept. 20 /PRNewswire-FirstCall/-- DURECT Corporation (Nasdaq: DRRX) announced today that James Brown, President and CEO, will present at the UBS Global Life Sciences Conference in New York on September 27, 2007 at 1:30 p.m. Eastern Time.
A live audio webcast of the presentation will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations." If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit http://www.durect.com.
SOURCE DURECT Corporation
CONTACT: Matthew J. Hogan, Chief Financial Officer of DURECT Corporation, +1-408-777-4936
Web site: http://www.durect.com